Latest in News & Research

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

Proportion of adults, adolescents achieving SALT score of 20 or less significantly higher with upadacitinib versus placebo

By Dermsquared Editorial Team | | August 18, 2026

New Melanoma Drug Based On Herpes Virus Granted FDA Accelerated Approval

The approval follows clinical trial data showing tumor shrinkage in 1 in 4 patients

By Haley Neff (HealthDay News) | | August 18, 2026

Risk for Herpes Zoster Elevated for Individuals With Atopic Dermatitis

Minimal reductions seen in association with adjustment for definitions of oral corticosteroid exposure, other traditional immunosuppressants

By Elana Gotkine (HealthDay News) | | August 18, 2026

Early Respiratory Infections Linked to Atopic Dermatitis Diagnosis

Each infection episode linked to increased risk for AD, independent of systemic antibiotic treatment, FLG variants

By Elana Gotkine (HealthDay News) | | August 18, 2026

Burden of Myocardial Dysfunction Elevated for Individuals With Psoriasis

Association persisted after adjustment for cardiometabolic risk factors and atherosclerotic cardiovascular disease

By Elana Gotkine (HealthDay News) | | July 27, 2026

FDA expands ZORYVE (roflumilast) cream 0.3% indication to children as young as 2 years with plaque psoriasis

James Q. Del Rosso, DO, reviews the FDA approval, supporting clinical data, and what this expanded indication means for pediatric plaque psoriasis management.

By Dermsquared Editorial Team | | July 02, 2026

In CSU, Hives Are Only the Beginning

Chronic spontaneous urticaria may appear episodic, but for many patients, the real disease lives between the disrupted sleep, repeated treatment cycles, and the constant...

By Dermsquared Editorial Team | | July 01, 2026

Poly-L-Lactic Acid Safe, Effective for Correction of Décolletage Wrinkles

Improvement seen for participants assigned to PLLA-SCA with two reconstitution volumes

By Dermsquared Editorial Team | | June 22, 2026

Extra Lesions ID'd During Mohs Visits Are Often Nonmelanoma Skin Cancer

All lesions diagnosed as nonmelanoma skin cancer were excised on the same day as biopsy

By Dermsquared Editorial Team | | June 22, 2026

Melanoma Incidence and Deaths Disproportionately Impact Men

Authors say findings from people in Florida show persistent gaps in prevention and early detection

By Lori Solomon (HealthDay News) | | June 22, 2026

Oral Nicotinamide Cost-Effective for Preventing Keratinocyte Carcinoma

Nicotinamide use yielded 6.24 QALYs gained per year across the cohort assuming a 0.01-QALY decrement per KC

By Dermsquared Editorial Team | | June 22, 2026

Generally Mild, Managed Adverse Effects Seen With Combo Treatment for Hair Loss

37.7 percent of women had adverse effects, most commonly hypertrichosis and dizziness/lightheadedness/orthostasis

By Dermsquared Editorial Team | | June 22, 2026

FDA Approves First New Sunscreen Ingredient in Two Decades

Key Takeaways

  • The U.S. Food and Drug Administration approved bemotrizinol for U.S. sunscreens

  • This broad-spectrum filter doesn’t break down easily and shows low absorption...

By Deanna Neff (HealthDay News) | | June 22, 2026

Dose Reduction of Biologics Effective, Safe for Psoriasis

Dose reduction through stepwise interval prolongation of IL-17i, IL-23i effective in patients with stable low disease activity

By Meeta Shah, MD (HealthDay News) | | June 22, 2026

Culturally Sensitive Hair Loss Examination: A Framework for Advanced Practice Dermatology Providers

Culturally sensitive approaches to alopecia evaluation — This article highlights how clinicians can integrate cultural awareness, hair morphology knowledge, and respectful examination techniques to...

By KimberlyG. Baker, NP | | June 09, 2026

Familial Melanoma Genes May Increase Risk for More Cancers Than Previously Thought

Combined prevalence of pathogenic variants ranged from 0.5 to 0.9 percent in U.K. Biobank, U.S. Geisinger MyCode

By Dermsquared Editorial Team | | June 03, 2026

Gummy Nutraceutical Linked to Improvements in Hair Parameters

Xtressé was safe, tolerated, and associated with measurable improvements in women with nonscarring alopecia

By Dermsquared Editorial Team | | June 03, 2026

Atopic Dermatitis Linked to Increased Risk for Retinal Detachment

In the RD repair cohort, AD was also linked to increased risk for proliferative vitreoretinopathy and complex RD repair

By Elana Gotkine (HealthDay News) | | June 03, 2026

Many Seeking Skin Cancer Surveillance Care Have Low Risk for Skin Cancer

The authors suggest implementing triage criteria for asymptomatic patients seeking SC surveillance, based on age, skin phototype, and SC history

By Dermsquared Editorial Team | | June 03, 2026

Use of Isotretinoin in Adolescence Not Linked to Reduced Adult Height

Adjusted mean differences in height with isotretinoin below predefined minimal clinically important difference

By Dermsquared Editorial Team | | June 03, 2026

Text Messages Aid in Reducing Cardiovascular Risk in Adults With Psoriasis

Over six months, improvements seen in patient activation and cardiovascular risk behaviors

By Lori Solomon (HealthDay News) | | June 03, 2026

Distinct Regional Patterns Seen in Malignant Skin Cancer

Consistent increases seen in incidence in low-, middle-SDI regions, while trends vary in high-SDI regions

By Dermsquared Editorial Team | | June 03, 2026

Many Patients With Vitiligo Do Not Receive Treatment

Children and adolescents more often prescribed topical treatments; systemic treatments more often prescribed to adults

By Dermsquared Editorial Team | | June 03, 2026

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026